文献速递瓣膜外科主动脉外科

无支架生物主动脉瓣及根部置换的二十年经验:向患者告知风险与获益

Twenty-year experience with stentless biological aortic valve and root replacement: informing patients of risks and benefits.
PubMed 文献 · Eur J Cardiothorac Surg · 2018-01-01

该研究基于1993至2014年间604例接受Freestyle无支架生物瓣膜置换的患者,回顾性收集围术期数据、前瞻性收集随访数据(随访完整率96%,中位随访4.3年),构建竞争风险回归模型预测死亡、结构性瓣膜退化(SVD)及非SVD再手术概率。15年SVD、非SVD再手术和死亡概率分别为16.9%、8.1%和47.7%,模型纳入年龄、肾功能和植入技术,预测性能良好至中等,可用于医患共同决策。

要点

  • Freestyle无支架生物瓣长期SVD和瓣膜相关事件发生率低。
  • 15年SVD概率16.9%,非SVD再手术8.1%,死亡47.7%。
  • 预测模型含年龄、肾功能和植入技术,可辅助个体化决策。

核心结论

  • Freestyle无支架生物瓣是主动脉瓣或根部置换的有效瓣膜,长期随访中SVD和瓣膜相关事件发生率低。
  • 本研究设计的预测模型可向患者告知植入该瓣膜后的预期个体轨迹,改善医患共同决策。

研究设计与样本

  • 1993年至2014年间,604例患者接受Freestyle无支架生物瓣膜(143例瓣下、58例根部包涵、403例全根部置换)。
  • 围术期数据回顾性收集,随访数据自2015年前瞻性收集,随访完整率96%(中位4.3年),114例(19%)随访超过10年。
  • 构建竞争风险回归模型预测死亡、结构性瓣膜退化(SVD)及非SVD再手术概率。

主要发现

  • 患者中位年龄64岁,91例(15%)既往接受过主动脉瓣置换,351例(58%)接受同期手术。
  • 15年SVD、非SVD再手术和死亡概率分别为16.9%、8.1%和47.7%。
  • 人工瓣膜心内膜炎、血栓栓塞事件和出血的线性化发生率分别为每患者年0.5%、0.9%和0.1%。
  • 预测模型纳入年龄、肾功能和植入技术作为显著协变量,预测性能良好至中等,可达19年。

临床怎么用

  • 作者认为该预测模型可用于向患者告知植入该瓣膜后的预期个体轨迹,改善医患共同决策。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim of this study was to provide predictive data on the performance of the Freestyle stentless bioprosthesis that can be used to support and improve the shared decision-making process of prosthetic valve choice for aortic valve replacement. METHODS: Between 1993 and 2014, 604 patients received the Freestyle stentless bioprosthesis (143 subcoronary, 58 root inclusion and 403 full-root replacement). Perioperative data were collected retrospectively, and follow-up data were collected prospectively from 2015. Follow-up was 96% complete (median 4.3 years), with 114 (19%) patients having a follow-up period exceeding 10 years. A competing risks regression model was developed to predict the probability of mortality, structural valve deterioration (SVD) and reoperation for other causes than SVD. RESULTS: The median age of patients was 64 years, 91 (15%) patients had undergone previous aortic valve replacement and 351 (58%) underwent concomitant procedures. The 15-year probability of SVD, reoperation for other causes and death were 16.9%, 8.1% and 47.7%, respectively. Linearized occurrence rates for prosthesis endocarditis, thromboembolic events and bleeding were 0.5%, 0.9% and 0.1% per patient-year, respectively. The constructed predictive model, including age, renal function and implantation technique as significant covariates, had good to fair predictive performance up to 19 years. CONCLUSIONS: The Freestyle stentless bioprosthesis is an efficient prosthesis for aortic valve replacement or root replacement, with low incidences of SVD and valve-related events at long-term follow-up. The predictive model designed in this study can be used to fully inform patients about their expected individual trajectory after implantation of this prosthesis. This improves the shared decision-making process between patients and clinicians.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Schneider AW, Putter H, Hazekamp MG, et al. Twenty-year experience with stentless biological aortic valve and root replacement: informing patients of risks and benefits. Eur J Cardiothorac Surg. 2018. PMID: 29325103. doi:10.1093/ejcts/ezx478

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。